Methods: Prognostic models predicting PTS during acute care hospitalization and Year-1 and Year-2 post-injury were developed using a recent (TBI 2011(TBI -2014 cohort from the TBI Model Systems National Database. Potential PTS predictors were selected based on previous literature and biological plausibility. Bivariable logistic regression identified variables with a p-value<0.20 that were used to fit initial prognostic models. Multivariable logistic regression modeling with backward-stepwise elimination was used to determine reduced prognostic models and to internally validate using 1000 bootstrap samples. Fit statistics were calculated, correcting for over-fitting (optimism).
Introduction
Traumatic brain injury (TBI) is a well-recognized public health problem. Over 2.5 million TBIs occur annually in the United States 1 ; approximately 11% require hospitalization, primarily for moderate/severe injury. TBI is increasingly recognized as a chronic disease, significantly impacting morbidity and mortality 2;3 . As medicine advances, more individuals are expected to survive moderate/severe TBI, increasing the number affected by injury-associated complications.
Post-traumatic seizures (PTS) and epilepsy (PTE) are well-recognized TBI complications. PTS can develop at any point after TBI and is classified by time of first seizure (immediate: <24hrs, early:
24hrs to 7d, and late: >7d post-TBI). Immediate and early PTS are considered provoked: directly related to the primary injury. Late seizures are attributed to secondary injury cascades and persistent epileptogenic mechanisms, and if recurrent and otherwise unprovoked, represent PTE 4;5 . PTS incidence and prevalence vary widely throughout the literature and depend on study design (e.g. length of follow-up), population characteristics (e.g. injury severity), and PTS definition. Previous reports after primarily closed-head injury indicate a broad range of percent affected (early: 1.4-12%; late: 4.4-18.9%) [6] [7] [8] [9] [10] [11] . Work using the Traumatic Brain Injury Model System (TBIMS) National Database, including individuals with predominantly closed-head moderate/severe TBI, demonstrated prevalence rates of 8.9% and 1.8% for immediate and early PTS, respectively 12 . By 1yr post-injury, 20.4% of the cohort reported seizures, 12% met criteria for late PTS (i.e. PTE). Late PTS prevalence at 2yrs and 5yrs post-TBI increased to 16.8% and 20.5% 12 . Incident seizure risk after severe TBI, beyond 10yrs post-injury, remains significantly elevated versus the general population 6 . These data suggest epileptogenesis can follow a prolonged course, and TBI related pathology exerts long-term epileptogenic effects.
Prognostic models can estimate an individual's risk for developing an outcome of interest based on specific characteristics 13 . While many studies examined injury characteristics and associations with PTS, few have developed prognostic PTS models. Of these, none have been integrated into routine clinical practice. Such models were developed decades ago, using small samples, and examining probability based on a single risk factor 14;15 . A multivariable mathematical model was developed in the 1970's and validated using datasets from TBI studies available at the time 16 . However, these prognostic models do not reflect current trends in injury severity, TBI detection and treatment, or seizure prophylaxis. Since then, improved neuroimaging allows greater specificity when characterizing intracranial pathology. Neurosurgical procedures, including craniectomy, are now more common for treating intracranial pathology. Therefore, new prognostic models reflecting current injury, diagnosis, and treatment trends are required if models are to be clinically useful. Accurate PTS risk prediction could help define high-risk populations in support of clinical intervention trials. Predictive models could also inform clinical algorithms to identify individuals likely to benefit from tailored seizure prophylaxis or treatment.
The TBIMS National Database (TBIMS-ND) is an ongoing, multi-center, longitudinal observational study. Currently, there are 16 funded centers collecting demographic, premorbid personal and medical history, and injury-specific data upon study enrollment, as well as chronic medical conditions, psychosocial, and rehabilitation outcomes. The TBIMS-ND is an excellent source of data for prognostic model development involving a variety of TBI-related outcomes for individuals surviving acute injury and receiving inpatient rehabilitation. Therefore, the aim of this study was to develop and internally validate prognostic models predicting PTS during acute care hospitalization, at Year-1, and
Year-2 post-injury for a recent cohort in the TBIMS-ND.
Methods

Study Design and Population
Data were obtained from the TBIMS-ND. All participating centers have a Level-I or Level-II 
Predictors of Interest
Predictors of interest included baseline demographics, personal and medical history information, and injury characteristics. All predictors were selected a priori based on biological plausibility and possible risk factors identified in previous literature 6-9;18-20 . Also, a contusion load score was calculated by summing the number of regions with reported contusion ( Table 1) . This score was collapsed into 0, 1, 2, 3, and 4 or more regions. Acute alcohol use was classified based on ICD-9 codes during acute hospitalization ( Table 1) . At Year-1 and Year-2, seizure during acute hospitalization was included as a risk factor. No data were collected on premorbid seizure activity or history of epilepsy.
Prognostic Modeling
Multivariable logistic regression was used to generate prognostic models for PTS during acute hospitalization, Year-1, and Year-2; models were internally validated with resampling. For each timepoint (PTS during acute hospitalization, PTS status since discharge from rehabilitation [Year-1], and PTS status in the past year [Year-2]), all potential risk factors described above were first examined using bivariate logistic regression. All variables with p-value<0.20 were retained for inclusion in multivariable model building.
A saturated (multivariable) logistic regression model, including all variables identified in the above step, was fit for each PTS time-point. After fitting a saturated model, variables were preliminarily examined for multicollinearity using Spearman correlation matrices. For each model, retained fragment and pTBI were highly collinear (r>0.9); pTBI occurred much less frequently versus retained fragment, and therefore, was not included in further prognostic modeling. Premorbid history of MH disorder and premorbid psychiatric hospitalization were also highly collinear and were combined to form a four-level Table 2) . Based on these data, 91% of the population with seizure data during acute hospitalization was used to generate Year-1 prognostic models, and 60% of the population at acute hospitalization was used to generate Year-2 prognostic models. The Year-2 sample size is smaller than acute and Year-1 samples, due to many subjects not yet reaching their Year-2 follow-up time point.
Prognostic Models
Following bivariate examination of predictors, 15 variables met inclusion criteria (p<0.20) for the initial, saturated prognostic model of PTS during acute hospitalization (Supplemental Table 1 ). After backward elimination and bootstrapping, the final model included sex, pre-injury limitation in learning/concentrating/remembering, contusion load, and craniotomy. Craniotomy was among the most statistically significant predictors in the final prognostic model and was selected in 85% of bootstrapped models (Supplemental Table 1 ). After correction for optimism, the C-statistic in the final model was 0.599 ( Table 3 ).
The Year-1 saturated prognostic model of PTS included 22 predictor variables ( Table 4) . After validation, the final model included injury severity, SDH, contusion load, craniotomy, craniectomy, seizure during acute hospitalization, pre-injury condition limiting physical activity, pre-injury MH treatment/psychiatric hospitalization, and incarceration. Craniectomy was the most statistically significant predictor and was selected in 100% of bootstrap samples ( Table 4 , Figure 1 ). After adjustment for optimism, the calculated C-statistic for the Year-1 model was 0.747 ( Table 3 ).
The Year-2 saturated model included 21 predictor variables ( Table 5) . After validation, SDH, intraparenchymal fragment, craniotomy, craniectomy, seizure during acute hospitalization, and preinjury incarceration were retained. Acute hospitalization seizure and craniectomy were the most statistically significant predictors of PTS at Year-2 and were selected in 99 and 95% of bootstrap samples, retrospectively. After correction for optimism, the C-statistic was 0.716 ( Table 3) .
Discussion
Over time, observational studies have identified relevant clinical, demographic, and premorbid variables that impact PTS risk after TBI 6;8;9;19 . However, no recent studies have attempted to develop and validate prognostic models for PTS based on identified risk factors. Based on this information and our hypotheses regarding the relevance of variables collected in the TBIMS, we developed prognostic models for PTS during acute hospitalization, at Year-1, and Year-2 following TBI for individuals requiring acute hospitalization and receiving inpatient rehabilitation at designated TBIMS centers. We internally validated these models using resampling techniques and generated discrimination statistics.
Within each model, multiple risk factors were significant predictors of PTS. C-statistics demonstrated that models had fair to good ability to discriminate between individuals with and without PTS at Year-1
and Year-2. However, the prognostic model for acute hospitalization did not perform much better than chance for predicting PTS. Nonetheless, variables identified as PTS predictors over time may shed light on vulnerable risk groups and the temporal nature of specific clinical and demographic PTS risk factors.
Previous early PTS studies have not extensively examined demographic characteristics as risk factors. Sex was the only significant demographic PTS predictor (men at increased risk) and only in the acute care model. This finding must be interpreted with caution because of the model's poor discrimination ability. Age, however, has been documented as a risk factor for early (young children at increased risk versus adults 7;19 ) and late PTS (among adults, individuals greater than 65 at increased risk). Though we examined age, and it was selected for inclusion in each multivariable model based on bivariate logistic regression, age was not a significant predictor in final multivariable prognostic models.
This finding may be attributed to correlation (shared variance) among age and other variables included in final prognostic models such as pre-injury or injury characteristics (SDH, contusion load, limitation in learning/remembering/concentrating) (data not shown). Subsequently, when examined in multivariable models, other predictors may be stronger indicators of PTS risk, therefore excluding age from models.
We identified pre-injury limitation in learning, remembering, or concentrating as a significant Contrary to expectation, previous moderate/severe TBI did not predict PTS. To our knowledge, no previous study has examined PTS risk after multiple moderate/severe TBI. We hypothesized pathology from prior injury increases PTS risk after subsequent injury. However, the lack of significant findings may be related to low event rates, with less than 3.5% of the population reporting prior moderate/severe TBI. Future work should investigate how multiple TBI affects biosusceptibility to complications like PTS.
Intraparenchymal fragment was a significant PTS predictor at Year-2, consistent with previous research demonstrating higher PTS rates among those with depressed skull fracture 6-8 and pTBI 32 . In our analyses, pTBI was very rare, but also partially defined by the intraparenchymal fragment variable, and was therefore not examined in prognostic models. Injury severity was examined, but not included as a significant PTS predictor at each time point. The lack of predictive ability may be attributed to low sample size or inclusion of other variables associated with injury severity (i.e. intracranial pathologies, craniectomy).
SDH was a significant predictor at Year-1 and Year-2, consistent with previous literature 6;8;20 .
SDH was not a significant PTS predictor acutely, but the propensity for temporal glial scarring in SDH regions, and the fundamental role of glial scarring in epileptogenesis 33;34 may explain the temporality of this finding. Contusion load was a significant predictor acutely and at Year-1, and is likely a marker of multifocal injury throughout the brain; contusion has been identified previously as a risk factor for PTS 6; 8; 20 . As contusion load increases, neuronal injury and apoptosis likely increase, disrupting neuronal circuits and predisposing focal areas to ictal discharges. Vascular damage after TBI leads to regional blood extravasation and subsequent generation of blood breakdown products within CNS tissues, perpetuating oxidative stress, another mechanism of epileptogenesis 4;5 .
Seizure during acute hospitalization was a significant PTS predictor at Year-1 and Year-2.
Although there is debate regarding the "seizure begets seizure" construct 35 , research consistently demonstrates early seizure is associated with increased risk of late PTS . While acute hospitalization for the TBIMS population often extends beyond the first week post-TBI, the finding that these seizures contribute to longer term PTE risk underscores the critical need for effective PTS prophylaxis and revisiting if/how current guidelines for medication and treatment duration prevent immediate/early PTS effectively and reduce PTE risk 38 .
Craniotomy and craniectomy are common procedures following severe TBI. Recently, decompressive craniectomy (DC) has become a widely used procedure for management of intractable intracranial pressure. Cranial surgeries were among the strongest and most statistically significant PTS predictors in our models, confirming previously published findings 8;20 . However, cranial surgery type reaching statistical significance within models varied across time. We hypothesize this association may stem from both anatomic and physiologic changes from the craniectomy and associated cranioplasty as well as late surgical complications.
Craniotomy and craniectomy are implicated as risk factors for seizure, even when used to address non-traumatic CNS pathologies 39 . Craniectomy carries increased risk for additional brain tissue damage during surgery and secondary to post-operative hematoma and edema 40 . Chronic complications (>1month post-surgery) can occur post-craniectomy, including poor wound healing, infection, and hydrocephalus 40 .
Complications and increased morbidity can also occur with subsequent duraplasty/cranioplasty 41 . Thus, delayed pathological mechanisms associated with chronic complications and subsequent cranioplasty may explain the temporality of craniectomy as a significant PTS predictor. Observational and retrospective studies note more severe injury among individuals undergoing craniectomy versus craniotomy or standard care 42 . Our prognostic models include multiple injury severity and pathology measures, yet craniectomy remained among the strongest predictors, supporting the idea that craniectomy is associated with increased PTS risk, independent of injury severity. PTS prophylaxis guidelines 38 do not reflect trends in neurosurgical intervention for TBI treatment and may benefit from additional research that considers these issues.
Although these are the first prognostic models to reflect current trends in TBI severity, diagnosis, and treatment which elucidate potentially important PTS predictors, there are important limitations to consider. Relative to prognostic studies in general, sample sizes in current analyses were small. Ability to discriminate PTS was poor during acute hospitalization. Low acute model performance may be due to the fact that seizure status during acute hospitalization does not differentiate between immediate, early, and late seizures. As a result, this study could not address the prediction of PTE during acute hospitalization per se. Differentiating between these time points as outcomes could improve individual model performance as PTS risk factors temporally evolve. Alternatively, factors predicting acute seizures may be so diverse that prognostic models would not be effective. Acute seizures may include those detected via electroencephalogram (EEG). However, we do not know if EEG was used to capture seizure activity, if specific individuals only were monitored using continuous EEG, or if EEG monitoring/screening practices differed across TBIMS centers.
Misclassification of PTS status during acute hospitalization from ICD-9 codes, the inability to determine premorbid seizure/epilepsy disorder, and Year-1/Year-2 PTS misclassification also limit model performance. Importantly, PTS status misclassification at Year-1 and Year-2 due to reliance on self-report can occur due to psychogenic seizure reporting or misreporting due to recall bias. However, for large epidemiological studies, it is not always feasible to determine PTS status through in-depth neurological examination or medical record review. Therefore, self-report remains a common practice for seizure/epilepsy 43 Lastly, the observational design does not provide causal evidence among relationships with PTS outcome.
Despite limitations, these prognostic models may have added benefit versus prior models, which were not used clinically even though they were reliable in multiple study populations 14;16 .
Previous models focused on calculating PTS probability or seizure recurrence over time [14] [15] [16] , while our prognostic models reflect current trends in TBI diagnosis, treatment, and population characteristics, and investigate multiple risk factors identified in previous PTS studies. Regardless, these models must be examined in independent study populations to determine discriminability and validity outside the TBIMS population. Individuals with characteristics identified in prognostic models as predictors of PTS represent subpopulations that may benefit from tailored seizure prophylaxis guidelines addressing unique premorbid characteristics, pathologies, and procedures.
Further study is required to determine whether new evidence of biological PTS risk factors improves the clinical utility of prognostic models. Year-1 and Year-2 models had optimism-corrected Cstatistics greater than 0.70 (0.747, 0.716, respectively). While these values indicate good discriminatory ability, there remains room for improvement. Moderating factors, including those occurring after the index TBI (e.g. ongoing EtOH and substance use, recurrent TBI) may influence the predictive capacity of our current models. Of particular interest are genetic factors previously shown to be associated with accelerated epileptogenesis and seizure risk after TBI 44;45 . These studies suggest genetic variation remains a significant PTS risk factor after controlling for other factors including injury severity and SDH.
Data regarding genetic variation in epileptogenic pathways could improve prognostic ability for PTS, much the way genetic information improved breast cancer prognostication 46 . As modern medical and prevention efforts for PTS move toward personalized medicine approaches, personal biology metrics like genetic variation and inflammation may contribute meaningfully to prognostication and treatment development. 
